Literature DB >> 19434731

Sporadic childhood Burkitt lymphoma incidence in the United States during 1992-2005.

Sam M Mbulaiteye1, Robert J Biggar, Kishor Bhatia, Martha S Linet, Susan S Devesa.   

Abstract

BACKGROUND: The risk factors and co-factors for sporadic childhood BL are unknown. We investigated demographic and age-specific characteristics of childhood BL (0-14 years) in the U.S. PROCEDURE: BL age-standardized incidence rates (2000 U.S. standard population), were calculated using data obtained from 12 registries in the NCI's Surveillance, Epidemiology, and End Results program for cases diagnosed from 1992 to 2005. Incidence rate ratios and 95% confidence intervals (95% CI) were calculated by gender, age-group, race, ethnicity, calendar-year period, and registry.
RESULTS: Of 296 cases identified, 56% were diagnosed in lymph nodes, 21% in abdominal organs, not including retroperitoneal lymph nodes, 14% were Burkitt cell leukemia, and 9% on face/head structures. The male-to-female case ratio was highest for facial/head tumors (25:1) and lowest for Burkitt cell leukemia (1.6:1). BL incidence rate was 2.5 (95% CI 2.3-2.8) cases per million person-years and was higher among boys than girls (3.9 vs. 1.1, P < 0.001) and higher among Whites and Asians/Pacific Islanders than among Blacks (2.8 and 2.9 vs. 1.2, respectively, P < 0.001). By ethnicity, BL incidence was higher among non-Hispanic Whites than Hispanic Whites (3.2 vs. 2.0, P = 0.002). Age-specific incidence rate for BL peaked by age 3-5 years (3.4 cases per million), then stabilized or declined with increasing age, but it did not vary with calendar-year or registry area.
CONCLUSIONS: Our results indicate that early childhood exposures, male-sex, and White race may be risk factors for sporadic childhood BL in the United States. Published 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19434731      PMCID: PMC2713377          DOI: 10.1002/pbc.22047

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  29 in total

Review 1.  Persistence of the Epstein-Barr virus and the origins of associated lymphomas.

Authors:  David A Thorley-Lawson; Andrew Gross
Journal:  N Engl J Med       Date:  2004-03-25       Impact factor: 91.245

2.  Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study.

Authors:  G de-Thé; A Geser; N E Day; P M Tukei; E H Williams; D P Beri; P G Smith; A G Dean; G W Bronkamm; P Feorino; W Henle
Journal:  Nature       Date:  1978-08-24       Impact factor: 49.962

Review 3.  Endemic Burkitt's lymphoma: a polymicrobial disease?

Authors:  Rosemary Rochford; Martin J Cannon; Ann M Moormann
Journal:  Nat Rev Microbiol       Date:  2005-02       Impact factor: 60.633

Review 4.  An epidemiologist's view of the new molecular biology findings in Hodgkin's disease.

Authors:  N Mueller
Journal:  Ann Oncol       Date:  1991-02       Impact factor: 32.976

5.  International variations in the incidence of childhood lymphomas.

Authors:  C A Stiller; D M Parkin
Journal:  Paediatr Perinat Epidemiol       Date:  1990-07       Impact factor: 3.980

6.  TCL1 expression and Epstein-Barr virus status in pediatric Burkitt lymphoma.

Authors:  Michael A Teitell; Mark A Lones; Sherrie L Perkins; Warren G Sanger; Mitchell S Cairo; Jonathan W Said
Journal:  Am J Clin Pathol       Date:  2005-10       Impact factor: 2.493

Review 7.  Epidemiology of non-Hodgkin's lymphoma: recent findings regarding an emerging epidemic.

Authors:  D D Weisenburger
Journal:  Ann Oncol       Date:  1994       Impact factor: 32.976

8.  Incidence and geographic distribution of endemic Burkitt lymphoma in northern Uganda revisited.

Authors:  Martin D Ogwang; Kishor Bhatia; Robert J Biggar; Sam M Mbulaiteye
Journal:  Int J Cancer       Date:  2008-12-01       Impact factor: 7.396

9.  Antibodies against malaria and Epstein-Barr virus in childhood Burkitt lymphoma: a case-control study in Uganda.

Authors:  Lucy M Carpenter; Robert Newton; Delphine Casabonne; John Ziegler; Sam Mbulaiteye; Edward Mbidde; Henry Wabinga; Harold Jaffe; Valerie Beral
Journal:  Int J Cancer       Date:  2008-03-15       Impact factor: 7.396

Review 10.  Adult Burkitt lymphoma: advances in diagnosis and treatment.

Authors:  Ibrahim T Aldoss; Dennis D Weisenburger; Kai Fu; Wing C Chan; Julie M Vose; Philip J Bierman; R Gregory Bociek; James O Armitage
Journal:  Oncology (Williston Park)       Date:  2008-11-30       Impact factor: 2.990

View more
  32 in total

1.  Incidence and trends in Burkitt lymphoma in northern Tanzania from 2000 to 2009.

Authors:  Peter Aka; Esther Kawira; Nestory Masalu; Benjamin Emmanuel; Glen Brubaker; Josiah Magatti; Sam M Mbulaiteye
Journal:  Pediatr Blood Cancer       Date:  2012-05-22       Impact factor: 3.167

Review 2.  Pediatric lymphomas and histiocytic disorders of childhood.

Authors:  Carl E Allen; Kara M Kelly; Catherine M Bollard
Journal:  Pediatr Clin North Am       Date:  2015-02       Impact factor: 3.278

3.  A population-based study of the prevalence and risk factors of low-grade Plasmodium falciparum malaria infection in children aged 0-15 years old in northern Tanzania.

Authors:  S Peprah; H Dhudha; H Ally; N Masalu; E Kawira; C N Chao; I O Genga; M Mumia; P A Were; T Kinyera; I Otim; I D Legason; R J Biggar; K Bhatia; J J Goedert; R M Pfeiffer; S M Mbulaiteye
Journal:  Trop Med Int Health       Date:  2019-04-01       Impact factor: 2.622

4.  AIDS-related Burkitt lymphoma in the United States: what do age and CD4 lymphocyte patterns tell us about etiology and/or biology?

Authors:  Mercy Guech-Ongey; Edgar P Simard; William F Anderson; Eric A Engels; Kishor Bhatia; Susan S Devesa; Sam M Mbulaiteye
Journal:  Blood       Date:  2010-09-02       Impact factor: 22.113

5.  Sex ratio among childhood cancers by single year of age.

Authors:  Lindsay A Williams; Michaela Richardson; Erin L Marcotte; Jenny N Poynter; Logan G Spector
Journal:  Pediatr Blood Cancer       Date:  2019-02-28       Impact factor: 3.167

6.  Pediatric, elderly, and emerging adult-onset peaks in Burkitt's lymphoma incidence diagnosed in four continents, excluding Africa.

Authors:  Sam M Mbulaiteye; William F Anderson; Jacques Ferlay; Kishor Bhatia; Cindy Chang; Philip S Rosenberg; Susan S Devesa; Donald M Parkin
Journal:  Am J Hematol       Date:  2012-04-10       Impact factor: 10.047

7.  Gastric Burkitt's lymphoma in a child: A rare case.

Authors:  Rossella Angotti; Mario Marini; Giulia Giannotti; Andreina Burgio; Daniela Meucci; Maria Pavone; Mario Messina
Journal:  Oncol Lett       Date:  2012-07-05       Impact factor: 2.967

8.  Trimodal age-specific incidence patterns for Burkitt lymphoma in the United States, 1973-2005.

Authors:  Sam M Mbulaiteye; William F Anderson; Kishor Bhatia; Philip S Rosenberg; Martha S Linet; Susan S Devesa
Journal:  Int J Cancer       Date:  2010-04-01       Impact factor: 7.396

9.  Burkitt and Burkitt-Like Lymphomas: a Systematic Review.

Authors:  Khalil Saleh; Jean-Marie Michot; Valérie Camara-Clayette; Yegor Vassetsky; Vincent Ribrag
Journal:  Curr Oncol Rep       Date:  2020-03-06       Impact factor: 5.075

10.  Xanthogranulomatous Appendicitis Mimicking Residual Burkitt's Lymphoma After Chemotherapy.

Authors:  Soomin Nam; Jeonghyun Kang; Sung-Eun Choi; Yu Ri Kim; Seung Hyuk Baik; Seung-Kook Sohn
Journal:  Ann Coloproctol       Date:  2016-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.